Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2160265029;65030;65031 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
N2AB1996160106;60107;60108 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
N2A1903457325;57326;57327 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
N2B1253737834;37835;37836 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
Novex-11266238209;38210;38211 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
Novex-21272938410;38411;38412 chr2:178584837;178584836;178584835chr2:179449564;179449563;179449562
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Fn3-44
  • Domain position: 44
  • Structural Position: 50
  • Q(SASA): 0.2875
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I None None 0.4 N 0.247 0.204 0.377097596864 gnomAD-4.0.0 6.84345E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99628E-07 0 0
V/L rs2048571659 None 0.911 N 0.467 0.232 0.368743488249 gnomAD-4.0.0 4.10606E-06 None None None None N None 2.98989E-05 0 None 0 0 None 0 0 0 0 8.28638E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.2131 likely_benign 0.2301 benign -1.375 Destabilizing 0.953 D 0.499 neutral N 0.464647104 None None N
V/C 0.7351 likely_pathogenic 0.7609 pathogenic -0.978 Destabilizing 1.0 D 0.568 neutral None None None None N
V/D 0.5347 ambiguous 0.6128 pathogenic -0.986 Destabilizing 0.998 D 0.683 prob.neutral None None None None N
V/E 0.4337 ambiguous 0.5079 ambiguous -1.026 Destabilizing 0.997 D 0.632 neutral N 0.508475239 None None N
V/F 0.2612 likely_benign 0.2924 benign -1.226 Destabilizing 0.998 D 0.536 neutral None None None None N
V/G 0.2905 likely_benign 0.3273 benign -1.643 Destabilizing 0.997 D 0.669 neutral N 0.499973186 None None N
V/H 0.7031 likely_pathogenic 0.7546 pathogenic -1.098 Destabilizing 1.0 D 0.708 prob.delet. None None None None N
V/I 0.0793 likely_benign 0.0792 benign -0.76 Destabilizing 0.4 N 0.247 neutral N 0.479155196 None None N
V/K 0.4824 ambiguous 0.5626 ambiguous -1.045 Destabilizing 0.998 D 0.631 neutral None None None None N
V/L 0.2404 likely_benign 0.2682 benign -0.76 Destabilizing 0.911 D 0.467 neutral N 0.487350605 None None N
V/M 0.1683 likely_benign 0.1918 benign -0.549 Destabilizing 0.998 D 0.554 neutral None None None None N
V/N 0.3593 ambiguous 0.3998 ambiguous -0.807 Destabilizing 0.998 D 0.693 prob.neutral None None None None N
V/P 0.5933 likely_pathogenic 0.6479 pathogenic -0.929 Destabilizing 0.999 D 0.641 neutral None None None None N
V/Q 0.4659 ambiguous 0.5404 ambiguous -1.034 Destabilizing 0.999 D 0.656 neutral None None None None N
V/R 0.4497 ambiguous 0.5364 ambiguous -0.466 Destabilizing 0.998 D 0.696 prob.neutral None None None None N
V/S 0.2692 likely_benign 0.2936 benign -1.338 Destabilizing 0.991 D 0.574 neutral None None None None N
V/T 0.1843 likely_benign 0.2044 benign -1.268 Destabilizing 0.671 D 0.245 neutral None None None None N
V/W 0.8785 likely_pathogenic 0.916 pathogenic -1.327 Destabilizing 1.0 D 0.697 prob.neutral None None None None N
V/Y 0.6512 likely_pathogenic 0.7053 pathogenic -1.05 Destabilizing 0.999 D 0.546 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.